Dutch biotech firm Pharming announced that it has made significant progress with financing towards completion of the transaction with subsidiaries of Valeant Pharmaceuticals signed on 8 August 2016 for Pharming to acquire the commercialization rights to its own product Ruconest in North America.
According to an article in the Telegraaf an implantable capsule made of biological material is regarded as as possible breakthrough treatment of diabetes type 1. Scientists from four Dutch universities work together on this spectacular new transplant technique.
The same day the Dutch Bureau of Statistics announced that the number of people suffering from diabetes in the Netherlands is relatively low when compared to other European countries.
MyLife Technologies, a spin-off originating from the University of Utrecht, has secured an 500.000 euro investment for it’s vaccine or medicine administering band-aid.
Nasdaq listed Dutch biotech company Uniqure this Wednesday announced plans for dismissing about 60 of it’s employees. Most jobs will be lost at the company’s headquarters in Amsterdam.
Pfizer has stepped up it’s production of Salazopyrine to reverse an impending shortage on the Dutch market. The manufacturer reports that there will be more than enough Salazopyrine available from Friday November 18th to provide all patients. About 16.000 patients in the Netherlands use Salazopyrine, according to the Dutch Reumafonds.
A training program for paediatricians and a 2 million euro extra funding for longer conversations with parents. That way the Dutch National Institute for Health and the Environment (RIVM) wants to remove concerns among parents about the vaccination of their children. The RIVM reported a growing number of parents asking questions to determine whether they want their children to participate in the national vaccination program.
Compared to ten other highly developed Western countries, the Dutch healthcare system is doing more than fine. This can be said according to a study published by The Commonwealth Fund (CWF), an American think tank focused on healthcare.
KNMP, the Dutch Ministry of Health and the Dutch Health Care Inspectorate have agreed on the implementation of the European delegated regulation on counterfeit medicines, called the Falsified Medicines Directive (FMD). This European Directive aims to prevent falsified medicines from entering the legal circuit. This allows pharmacists in the Netherlands to continue to work with medication roles smartfilling and central filling. Furthermore, the required scan control may take place at any time in the pharmacy before medicines are handed out.
Researchers from Radboud University and Radboud Medical Centre in Nijmegen think they have found a way to effectively combat sepsis. They have discovered a given sugar, by which immune cells are activated in order to deal with infections. The discovery came about after five years of study. 54 research teams participated in twelve countries, including the Netherlands.
Sanofi heeft aangekondigd van plan te zijn de productie van het blaaskankermedicijn TheraCys te stoppen. Dit vanwege een hardnekkig problemen met de steriliteit in de fabriek in Toronto waar het middel wordt geproduceerd.